BACKGROUND: In 2003, the World Health Organization reported that 50% of patients are adherent to long-term therapies. Frequently, the reason for a patient's nonadherence is the cost of medicat ions. Even with prescription insurance coverage, patients maynotbe able to afford their medications. OBJECTIVE: To assess prescriber knowledgeof the cost of commonly prescribed medications incl uding alorvastatin, gabapentin, Ievofloxacin, Iosartan, pantoprazole, pioglitazone, and quetiapine. Secondary objectives were to evaluate how often prescribers consult a discounted drug list and a patient's prescription insurance coverage. METHODOLOGY: One hundred prescribers from the Medical University of South Carolina were surveyed from November 2010 to January 2011. Prescribers consisted of medical residents, attending physicians, fellows, nursepractitioners, and physician assistants. Wholesale prices of medications were determined using the Red Book, and prescription insurance priceswere calculated from an average of the top 3 prescription insurance companies' copayments. RESULTS: Medical residents made up72%of those surveyed, fellows 3%,attencling physicians 12%, physician assistants 3%, and nurse practitioners 10%. The prescriber groupswere unableto correctly determine the cost of medications of more than 50%of total possible responses. Themajority of prescribers rarely asked about a patient'sprescription insurance coverage or consulted a discounted drug list before writing a prescription. CONCLUSIONS: Prescribers are more likely to know the cost of medications for patients who haveprescription insurance coverage versus those whodo not.
gram for all involved, and addressing barriers to adherence.
Factors affecting a patient's medication adherence can be nonintentional or intentional and behavioral or processoriented; they include problems related to the drug, pharmacy, patient, prescriber, or govemment.v' Some examples of barriersthat patientsface when taking medications correctly include the value of health to the patient,how complicated the regimen is, physical barriers to receiving the prescription, and patient-physician relationships. 6 Frequently,the most influential reason for a patient's nonadherence is the cost of medications. Patients who do not have prescription insuranceare charged for the full medication cost. Those who do have prescription coverage, however, pay a copayment. Even if covered by prescription insurance,patients may not be able to afford medications because of costly copayments" Patterson et al. found that patients with heart failure were less adherentto their j3-blocker regimen if their copayment was $21 or higher," Unfortunately, patients who choose not to take their drug therapy as prescribed could be putting themselves at risk for developing complicationsor even death from theirdisease.
The primary objective of this study was to determine how much money prescribers believe patients with and without prescription insurance coverage pay for certain medications. Secondary objectives included determining how often prescribersconsulted a discountedprescription drug list and a patient'sprescription insurance coverage.
Methods
A survey that we created was given to prescribers at an academic medical center to assess their knowledge of the cost of medications. Responses from the survey could then be used to identify areas in which pharmacistscould help intervene to increase patient adherence and decrease healthcare-associated costs to both the patient and the facility.
Prescribersfrom the Medical University of South Carolina (MUSe) were surveyed from November 2010 to January 2011. A copy of the survey is available as Appendix I. One hundred prescribers, consisting of medical residents, attending physicians, fellows, nurse practitioners and physician assistants from both the inpatient and outpatientsettings, responded to the survey, representing a small sample of hundreds who were eligible. Project approval Was obtained from the institutional review board.
The surveys were placed in computer work areas on each of the floors with a notice for prescribers to fill them out anonymously. Chief residents were asked to encourage house staff to complete the surveys. Additional surveys Were distributedto interprofessional teams in which there Was at least 1 practicing pharmacist. Both the inpatient and outpatient settings comprise interprofessional teamsthat include physicians, pharmacists, nurse practitioners, and sometimes physician assistants. The make-up of each team is determined by the location of practice within the hospital.
The survey consisted of 3 questions asking for the prescriber's profession, how often prescribers were aware of their patients' prescription insurance coverage, and how often they consulted a discounted drug list. The final 7 questions required the prescriber to circle the cost to patients with and without prescription insurance for one of the selected medications. The authors selected medications commonly prescribed at our institution and ensured that thosechosencould be used for commonconditions seen in primary care locally and nationally and for multiple indications.Some medications were available as a generic. Drugs selected for the survey were atorvastatin,gabapentin,levofloxacin, losartan,pantoprazole,pioglitazone,and quetiapine. Medications that were available as a generic at the time of the surveywere denotedwith an asterisk. These included gabapentin,losartan, and pantoprazole.Both trade names and generic names were provided on the survey for completeness.
The cost of all medications was assessed for a typical 30-day supply except for levofloxacin, which was for 10 tablets. For each agent,the averagecost was divided into 4 separate categories. Categorical groups, determinedby the authors, were based on average wholesale prices (AWPs) and average prescription insurance copayments for all of the survey medications. For patients without prescription insurance coverage,the pricing categories included$20 or less, $21-50,$51-99, and $100 or more. For patients with prescription insurance coverage, the average cost categories included $10 or less, $11-30, $31-49, and $50 or more.
AWPs from the 2010 edition of Red Book were used to determine the averagecost for each medication to a patient without prescription insurance," AWPs are not the most ideal measurement of cost but were used to negateany impact of negotiations between the pharmacies and generic manufacturers. For the patient with prescription coverage, the average copayments were calculated using the 2010 Kaiser/Health Research and Educational Trust Employer Health Benefits Survey." This annual report is published by the Kaiser Family Foundation and includes a compilation of prescription insuranceinformation from over 3000 randomly selected private and public firms. The survey found that 89% of employees coveredthrough prescription drug benefitplans in 20I0 were part of a tiered copayment system.The most frequent tiered system used by prescription insurance companies consistedof 3 categories: generic, preferred brand, and nonpreferred brand. Generic formulations correlate with lower copayments compared to nonpreferred brands, which have the highestcopayments.
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A medication was considered to be either preferred or nonpreferred based on formularies from the top 3 prescription insurance companies in 2010.11. 13 The top 3 health care insurance and managed care companies, including prescription insurance coverage, were determined by the Fortune 500 list, which takes into account gross revenue from top companies in the US each year," The top 3 companies for prescription insurance in 2010 consisted of United-Health Group, Wellpoint, and Aetna. Furthermore, United-Health Group and Wellpoint use separate third-party payers (Medco and Express Scripts, respectively) to handle their prescription insurance claims.P-" If a medication was considered to be a preferred brand on 1 formulary but not on another, an average of all 3 prices was calculated to determine the average copayment. AWPs and prescription insurance copayments for each medication are depicted in Tables 1 and 2 .11. 13 Descriptive statistics were used to characterize survey responses. The number of responses answered correctly from the various prescriber groups was calculated as a percentage and is depicted in Tables 1 and 2 . Wilcoxon signed-rank tests, ideal for analyzing paired observations of count data, were used to determine whether respondents were able to correctly identify medication costs more frequently for patients with prescription insurance compared to patients without prescription insurance. Comparisons between responses of nurses and those in other professions were made using Fisher exact tests.
Results
Of the 100 individuals surveyed, 72% were resident physicians, 12% attending physicians, 10% nurse practitioners, 3% fellows, and 3% physician assistants. Of the 7 (16) ..sO
Gabapentin" (901$11)~O 31 (43. ..sO (8) ..sO
3) 0(0) 1 (10) 7 (7) ..sO ..sO ..sO 5 (6.9) 0 (0) 0 (0) 0 (0) 1 (10) 6 (6) NA 2 (2.8) medications included in the survey, the mean (SO) number whose costs were correctly estimated by prescribers was significantl y higher when patients were assumed to have prescription insurance coverage than when patients were assumed not to have prescription insurance coverage ( without prescription insurance, the proportion of prescribers who were able to determine the correct average cost for the asse ssed med ications was consistently low, ranging from 22.2% (pantoprazole) to 40.8 % (levofloxacin). Prescrib ers were also asked to report the number of times they referred to a discounted drug list (Table 3) . For every 10 patients seen, 32% of prescribers reported checking discounted medication lists 1-2 times. Fourteen percent reported never checking these lists. Nurse practitioners on average checked more often , with 70% consulting the list at least 3-4 times for every 10 patient s, compared with 54% of physicians. This difference was not statistically significant (p =0.5).
A total of 2 1% of prescribers admitted to never consulting a patient's prescription insurance coverage before pre- (Table 3 ). In addition, the majority of prescribers who reported consulting a patient's prescription insurance coverage did so in no more than half of their patients . Nurse practitioners were the group most likely to check a patient's prescription insurance, with 30% reporting that they checked coverage for 5-6 patients of every 10 seen . Since only 10 responders were nurse practitioners, this was not statistically significant (p = 0.7). Only 11% of prescribers consulted with the patients about their prescription insurance coverage 90-100% of the time.
Discussion
Results from our survey show that prescriber groups were able to successfully determine the cost of a select number of medications less than half of the time. Fellows were the most accurate, assessing 48% of the total possible answers correctly. However, drawing conclusions from this would be inappropriate since there were only 3 individuals in this group. The largest group, resident physicians, accurately predicted the cost of a medication 39% of the time, independent of prescription insurance coverage.
To help alleviate problems associated with cost, many retail pharmacies have begun to offer a list of medications at a discounted rate such as the $4 lists available at Walmart and Kmart. Prescription assistance programs are also available for some medications to help reduce the cost for patients who meet certain criteria." Unfortunately, as the survey results show, prescribers are not often looking at the discounted drug lists and rarely determine a patient's prescription insurance coverage. Only 38% of all prescribers who answered the survey reported checking a discounted drug list the majority of the time. One method to increase the amount of time a prescriber considers using these resources is to increase accessibility to the lists and patient assistance programs. For example, links to discounted drug lists can possibly be provided on our institution's homepage or hard copies can be placed near computer work areas as a quick reference . The phone number to our patient assistance program coordinators can be placed on every work phone as well. Open communication between the physician and patient has been identified as another possible solution to helping improve medication adherence." The TRIAD (Translating Research into Action for Diabetes) study performed by Schmittdiel et al. evaluated the effects of physician communication and medication costs in a group of Medicare Part D beneficiaries and physicians. Of those who responded to the survey, 44% of patients discussed the cost of medications with their physician. The majority of these patients stressed the desire to discuss cost with their physicians and for physicians to take cost into consideration, with 76% and 80% responding, respectively. Groups that were less likely to have discussions about cost with their physician included females, minority patients, and patients older than 75.
In a similar survey performed by Piette et al., 17% of patients admitted to I or more instances in which they underused medications in the past year to cut costs." The chief reason patients gave when asked why they had not approached the subject with their physicians was that they were never asked about it. In addition, a survey of 1400 cardiologists and general internists by Alexander et al . found that the biggest barrier the prescribers had when talking to patients was about the cost of medications. ls Our study showed that only 34% of the prescribers reported speaking to their patients regarding their prescription insurance coverage more than half the time. Prescribers could improve upon their open communication regarding cost and adherence, especially in patients who are at higher risk of not approaching the subject voluntarily, by incorporating into every visit a question about the patient's ability to afford prescribed medications.
Despite the significant finding that prescribers' knowledge on the cost of medications is poor, there are some limitations to our study design. The first limitation is that the surveys were voluntary and prescribers were self-selected. Some of the responders may not have been as familiar with the drugs as others , depending on their main area of practice . For example. pediatric residents may not have known what the costs of the medications included on the survey were, as these are mainly used in adults. In addition, we did not ask how long each prescriber had been practicing. A difference might have been seen between someone who had just graduated from medical school and had been practicing for less than a year versus someone who had been practicing for 20 years.
A distinction as to where the prescriber practices a majority of the time, whether in the inpatient or outpatient setting, was also not assessed. At our institution, prescribers are seldom limited in regard to formulary medications. We have an open formulary with moderate restrictions in the inpatient setting and no restrictions in the outpatient set-ting. Patients, however, may be limited by their prescription insurance coverage and ability to pay their copayment?" The percentage of correct responses may have been differenthad we focused more on regional prescription insurance prices instead of using national surveys to determine pricing for copayments.
Another limitation is that the survey was not validated prior to being placed in common work areas.Furtherlimitations were placed on the study because some of the survey questions could have been misinterpreted. For example, generic products were noted with an asterisk on the survey. Clear instructions, however, were not given as to which version, brand or generic, should be assessed for cost. Prescribers could have marked what they thoughtthe brand cost to be instead of the generic, skewing the percentage of incorrect responses. Also, the directions did not clearly distinguish between whether the prescribers were assessing for how much the medication cost or how much the patientwas willing to pay.
Finally, the medications that were included in the survey were similar in pricing, bothfor thosewithand without prescription insurance coverage.Fifteenrespondents chose to circle down I column instead of choosing the price they thought each medication cost. Eight of the 15 prescribers answered this way for both the "with insurance" and "without insurance" columns. A larger selection of drugs with various cost values may have shown a more significant difference in correctresponses from each prescriber group.
Although our study does have some limitations, the importantpoint is that most prescribers do not know the cost of medications. This represents one of many areas in which pharmacistscan help decrease health care costs for patients at our institution. Pharmacists here can start by taking a proactive approach to finding prescription insurance information in the electronic medical record and asking the patientor family member, or checking with the patient's local pharmacy,as to how much they typically pay for medications. The information found can then be relayed to the interprofessional team prior to patient dischargefrom the hospital or checkoutin the outpatient clinics. In addition, discounted drug listscan be placedaround the common work areas for ease of access to the prescribers as a quick reference. If the patientis not able to afford the medications, pharmacists can also serve as a patient advocate by recommending a less expensivealternative.
Although prescribers rarely check a patient's prescription insurance coverage, they are more likely to assess correctly the cost of medications for patients who have prescription insurance coverageversusthose who do not. Furthermore, prescribers seldom reference discounted drug lists available from various pharmacies to help choose potentially less expensive alternatives for patients. Future studies need to determine whether differences are seen in Assessment of Prescribers' Knowledge of theCostof Medications patient adherence and health care costs after pharmacists provide education and recommendations to prescribers concerning the cost of medications. METOOOLOGiA: Cien prescribientes de la Universidad Medicade Carolinadel Sur fueron encuestados de noviembre 2010a enero 20II. Los prescribientes consistfan de medicos residentes, medicos tratantes, medicos becados,profesionales de enfermerfa y medicosasistentes. Los preciosal por mayorde los medicamentos fueron deterrninados usando el RedBooky preciosde cubiertas de seguropara medicamentos recetados de un promedio de los copagosde las principales tres compafiias de seguroscon cubiertade medicamentos.
RFSULTADOS: Los medicos residentes conforrnaron el 72% de los encuestados, los medicosbecados e13%, los medicos tratantes e112%, los medicos asistentes el3% y los profesionales de enfermerfa ellO%. Los diferentes gruposde prescribientes fueron incapaces de determinar correctamente el costode los medicamentos en mas de 50% del totalde respuestas posibles. La mayorfa de los prescribientes rara vez pregunt6 sobrela cubiertade medicamentos recetados del segurodel paciente 0 consult6 una lista de medicamentos con descuentos antesde expedirla receta.
CONCLUSIONES: Los prescribientes tienenmayorprobabilidad de conocer el costode los medicamentos de aquellos pacientes que tienenseguro con cubiertade medicamentos recetados, en comparaci6n con aquellos que no 10tienen. 3) For every 10 patients seen, please circle the number of times you consult discounted prescription drug lists to prescribe a cheaper alternative: Never 1-2 3-4 5-6 7-8 9-10 4-10) For the following drugs, please circle the average price range you believe a patient would pay if they do not have prescription insurance coverage and also if they have prescription insurance coverage:
Average cost for patient Average cost for patient with Medication (# of tablets) without insurance ($US) insurance ($US) medicaments couverts par les compagnies d'assurancede leurspatients. 
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